论文部分内容阅读
我院于1991年8月至1992年3月应用高压氧加清检酶治疗冠心病心绞痛104例,取得了较好疗效,值得推广应用。 104例患者随机分为两组,高压氧加清检酶组(以下简称治疗组)和单用清检酶组(以下简称对照组)。治疗组52例,其中男38例,女41例,最大年龄75岁,平均年龄56.8岁。对照组52例,其中男40例,女12例,最大年龄70岁,最小年龄32岁,平均年龄54.3岁。根据《实用心脏病手册》、《内科病诊断荟萃》将心绞痛分为劳累型、自发型、混合型三型。治疗组劳累型35例、自发型11例、混合型6例。对照组劳累型34例、自发型11例、混合型7例。
Our hospital in August 1991 to March 1992 application of hyperbaric oxygen plus clearance of enzyme-treated coronary heart disease in 104 cases, and achieved good results, it is worth promoting the application. 104 patients were randomly divided into two groups, hyperbaric oxygen plus clearance group (hereinafter referred to as the treatment group) and single use of clearance enzyme group (hereinafter referred to as the control group). Treatment group of 52 patients, 38 males and 41 females, the maximum age of 75 years, mean age 56.8 years. The control group of 52 patients, 40 males and 12 females, the maximum age of 70 years, the minimum age of 32 years, mean age 54.3 years. According to “Practical Heart Disease Manual”, “medical disease diagnosis meta-analysis” angina pectoris into fatigue type, spontaneous type, mixed type three. Treatment group, 35 cases of fatigue, spontaneous 11 cases, mixed 6 cases. In the control group, 34 were fatigue type, 11 were spontaneous type and 7 were mixed type.